The overexpression of the epidermal growth factor receptor (EGFR) and the human epidermal growth factor receptor 2 (HER2) protein kinases leads to the stimulation of VEGF production and promotes angiogenesis in most human cancers [8,9]. This evidence concerns the gene ERBB2 and cancer.